161 related articles for article (PubMed ID: 7731018)
1. Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines.
Catarzi D; Cecchi L; Colotta V; Filacchioni G; Martini C; Tacchi P; Lucacchini A
J Med Chem; 1995 Apr; 38(8):1330-6. PubMed ID: 7731018
[TBL] [Abstract][Full Text] [Related]
2. Novel adenosine receptor ligands: 1,3-disubstituted[1]benzopyrano[2,3-c]pyrazol-4-ones. Synthesis and structure-activity relationships.
Colotta V; Cecchi L; Catarzi D; Melani F; Filacchioni G; Martini C; Tacchi P; Lucacchini A
Recept Channels; 1993; 1(2):111-9. PubMed ID: 8081715
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and A1 and A2A adenosine binding activity of some pyrano[2,3-c]pyrazol-4-ones.
Colotta V; Catarzi D; Varano F; Melani F; Filacchioni G; Cecchi L; Trincavelli L; Martini C; Lucacchini A
Farmaco; 1998 Mar; 53(3):189-96. PubMed ID: 9639867
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic heteroaromatic systems: [1]benzopyrano-pyrazol-4-ones as benzodiazepine receptor ligands.
Colotta V; Cecchi L; Melani F; Filacchioni G; Martini C; Gelli S; Lucacchini A
J Pharm Sci; 1991 Mar; 80(3):276-9. PubMed ID: 1646879
[TBL] [Abstract][Full Text] [Related]
5. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
Matuszczak B; Pekala E; Müller CE
Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
[TBL] [Abstract][Full Text] [Related]
6. 1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Mar; 43(6):1158-64. PubMed ID: 10737748
[TBL] [Abstract][Full Text] [Related]
7. High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones.
Savini L; Massarelli P; Nencini C; Pellerano C; Biggio G; Maciocco A; Tuligi G; Carrieri A; Cinone N; Carotti A
Bioorg Med Chem; 1998 Apr; 6(4):389-99. PubMed ID: 9597183
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
[TBL] [Abstract][Full Text] [Related]
9. 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-alpha]-quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Arch Pharm (Weinheim); 1999 Feb; 332(2):39-41. PubMed ID: 10233008
[No Abstract] [Full Text] [Related]
10. Tricyclic heteroaromatic systems pyrazolo[1,5-a]quinoxalines: synthesis and benzodiazepine receptor activity.
Colotta V; Cecchi L; Catarzi D; Conti G; Filacchioni G; Martini C; Giusti L; Lucacchini A
Farmaco; 1993 Aug; 48(8):1051-63. PubMed ID: 8216668
[TBL] [Abstract][Full Text] [Related]
11. An efficient and facile synthesis of new tetracyclic fused pyrazolo[4,3-c][1,2,4]triazino[4,5-a]quinolin-4(5H)-ones.
Gomaa MA; Ali HA
Mol Divers; 2018 Nov; 22(4):969-977. PubMed ID: 29971615
[TBL] [Abstract][Full Text] [Related]
12. Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-ones.
Colotta V; Cecchi L; Melani F; Catarzi D; Filacchioni G; Martini C; Giannaccini G; Tonelli M; Lucacchini A
Drug Des Discov; 1992 Jul; 8(4):325-39. PubMed ID: 1332785
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and binding studies of 1-arylpyrazolo[4,5-c]- and 2-arylpyrazolo[4,3-c]quinolin-4-ones. I.
Cecchi L; Melani F; Palazzino G; Filacchioni G; Martini C; Pennacchi E; Lucacchini A
Farmaco Sci; 1985 Jul; 40(7):509-16. PubMed ID: 2995118
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 4-hydroxy-2(1H)-quinolone derived chalcones, pyrazolines and their antimicrobial, in silico antimalarial evaluations.
Sarveswari S; Vijayakumar V; Siva R; Priya R
Appl Biochem Biotechnol; 2015 Jan; 175(1):43-64. PubMed ID: 25238919
[TBL] [Abstract][Full Text] [Related]
15. Tricyclic heteroaromatic systems: synthesis, [3H]flunitrazepam brain membrane binding inhibition, and structure-activity relationships of 2,3-dihydro-2-aryl-4-R-[1]benzopyrano[4,3-c]pyrazole-3-ones.
Colotta V; Cecchi L; Melani F; Palazzino G; Filacchioni G; Martini C; Giannaccini G; Lucacchini A
J Pharm Sci; 1989 Mar; 78(3):239-42. PubMed ID: 2542524
[TBL] [Abstract][Full Text] [Related]
16. High affinity central benzodiazepine receptor ligands. Part 2: quantitative structure-activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones.
Savini L; Chiasserini L; Pellerano C; Biggio G; Maciocco E; Serra M; Cinone N; Carrieri A; Altomare C; Carotti A
Bioorg Med Chem; 2001 Feb; 9(2):431-44. PubMed ID: 11249135
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
Poulsen SA; Quinn RJ
J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
[TBL] [Abstract][Full Text] [Related]
18. 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors.
Baraldi PG; Cacciari B; Dalpiaz A; Dionisotti S; Zocchi C; Pineda de las Infantas MJ; Spalluto G; Varani K
Arzneimittelforschung; 1996 Apr; 46(4):365-8. PubMed ID: 8740079
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of a new set of 2-arylpyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
J Med Chem; 2000 Aug; 43(16):3118-24. PubMed ID: 10956220
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
